Subcutaneous immunotherapy (SCIT) is a unique therapy for allergic disease because it provides symptomatic relief while modifying the allergic disease by targeting the underlying immunological mechanism.
This report aims to provide a comprehensive presentation of the global market for Subcutaneous Immunotherapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Subcutaneous Immunotherapy. This report contains market size and forecasts of Subcutaneous Immunotherapy in global, including the following market information:
Global Subcutaneous Immunotherapy Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Subcutaneous Immunotherapy market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Asthma Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Subcutaneous Immunotherapy include Anergis, HAL Allergy Group, Merck, Allergy Therapeutics, ALK-Abello, Stallergenes Greer and Laboratorios LETI, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Subcutaneous Immunotherapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Subcutaneous Immunotherapy Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Subcutaneous Immunotherapy Market Segment Percentages, by Type, 2022 (%)
Asthma
Allergic Rhinitis
Venom Allergy
Food Allergy
Global Subcutaneous Immunotherapy Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Subcutaneous Immunotherapy Market Segment Percentages, by Application, 2022 (%)
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies
Global Subcutaneous Immunotherapy Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Subcutaneous Immunotherapy Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Subcutaneous Immunotherapy revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Subcutaneous Immunotherapy revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Anergis
HAL Allergy Group
Merck
Allergy Therapeutics
ALK-Abello
Stallergenes Greer
Laboratorios LETI
Outline of Major Chapters:
Chapter 1: Introduces the definition of Subcutaneous Immunotherapy, market overview.
Chapter 2: Global Subcutaneous Immunotherapy market size in revenue.
Chapter 3: Detailed analysis of Subcutaneous Immunotherapy company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Subcutaneous Immunotherapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Subcutaneous Immunotherapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Subcutaneous Immunotherapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Subcutaneous Immunotherapy Overall Market Size
2.1 Global Subcutaneous Immunotherapy Market Size: 2022 VS 2029
2.2 Global Subcutaneous Immunotherapy Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Subcutaneous Immunotherapy Players in Global Market
3.2 Top Global Subcutaneous Immunotherapy Companies Ranked by Revenue
3.3 Global Subcutaneous Immunotherapy Revenue by Companies
3.4 Top 3 and Top 5 Subcutaneous Immunotherapy Companies in Global Market, by Revenue in 2022
3.5 Global Companies Subcutaneous Immunotherapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Subcutaneous Immunotherapy Players in Global Market
3.6.1 List of Global Tier 1 Subcutaneous Immunotherapy Companies
3.6.2 List of Global Tier 2 and Tier 3 Subcutaneous Immunotherapy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Subcutaneous Immunotherapy Market Size Markets, 2022 & 2029
4.1.2 Asthma
4.1.3 Allergic Rhinitis
4.1.4 Venom Allergy
4.1.5 Food Allergy
4.2 By Type - Global Subcutaneous Immunotherapy Revenue & Forecasts
4.2.1 By Type - Global Subcutaneous Immunotherapy Revenue, 2018-2023
4.2.2 By Type - Global Subcutaneous Immunotherapy Revenue, 2024-2029
4.2.3 By Type - Global Subcutaneous Immunotherapy Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Subcutaneous Immunotherapy Market Size, 2022 & 2029
5.1.2 Hospital Pharmacies
5.1.3 Online Pharmacies
5.1.4 Retail Pharmacies
5.2 By Application - Global Subcutaneous Immunotherapy Revenue & Forecasts
5.2.1 By Application - Global Subcutaneous Immunotherapy Revenue, 2018-2023
5.2.2 By Application - Global Subcutaneous Immunotherapy Revenue, 2024-2029
5.2.3 By Application - Global Subcutaneous Immunotherapy Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Subcutaneous Immunotherapy Market Size, 2022 & 2029
6.2 By Region - Global Subcutaneous Immunotherapy Revenue & Forecasts
6.2.1 By Region - Global Subcutaneous Immunotherapy Revenue, 2018-2023
6.2.2 By Region - Global Subcutaneous Immunotherapy Revenue, 2024-2029
6.2.3 By Region - Global Subcutaneous Immunotherapy Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Subcutaneous Immunotherapy Revenue, 2018-2029
6.3.2 US Subcutaneous Immunotherapy Market Size, 2018-2029
6.3.3 Canada Subcutaneous Immunotherapy Market Size, 2018-2029
6.3.4 Mexico Subcutaneous Immunotherapy Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Subcutaneous Immunotherapy Revenue, 2018-2029
6.4.2 Germany Subcutaneous Immunotherapy Market Size, 2018-2029
6.4.3 France Subcutaneous Immunotherapy Market Size, 2018-2029
6.4.4 U.K. Subcutaneous Immunotherapy Market Size, 2018-2029
6.4.5 Italy Subcutaneous Immunotherapy Market Size, 2018-2029
6.4.6 Russia Subcutaneous Immunotherapy Market Size, 2018-2029
6.4.7 Nordic Countries Subcutaneous Immunotherapy Market Size, 2018-2029
6.4.8 Benelux Subcutaneous Immunotherapy Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Subcutaneous Immunotherapy Revenue, 2018-2029
6.5.2 China Subcutaneous Immunotherapy Market Size, 2018-2029
6.5.3 Japan Subcutaneous Immunotherapy Market Size, 2018-2029
6.5.4 South Korea Subcutaneous Immunotherapy Market Size, 2018-2029
6.5.5 Southeast Asia Subcutaneous Immunotherapy Market Size, 2018-2029
6.5.6 India Subcutaneous Immunotherapy Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Subcutaneous Immunotherapy Revenue, 2018-2029
6.6.2 Brazil Subcutaneous Immunotherapy Market Size, 2018-2029
6.6.3 Argentina Subcutaneous Immunotherapy Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Subcutaneous Immunotherapy Revenue, 2018-2029
6.7.2 Turkey Subcutaneous Immunotherapy Market Size, 2018-2029
6.7.3 Israel Subcutaneous Immunotherapy Market Size, 2018-2029
6.7.4 Saudi Arabia Subcutaneous Immunotherapy Market Size, 2018-2029
6.7.5 UAE Subcutaneous Immunotherapy Market Size, 2018-2029
7 Subcutaneous Immunotherapy Companies Profiles
7.1 Anergis
7.1.1 Anergis Company Summary
7.1.2 Anergis Business Overview
7.1.3 Anergis Subcutaneous Immunotherapy Major Product Offerings
7.1.4 Anergis Subcutaneous Immunotherapy Revenue in Global Market (2018-2023)
7.1.5 Anergis Key News & Latest Developments
7.2 HAL Allergy Group
7.2.1 HAL Allergy Group Company Summary
7.2.2 HAL Allergy Group Business Overview
7.2.3 HAL Allergy Group Subcutaneous Immunotherapy Major Product Offerings
7.2.4 HAL Allergy Group Subcutaneous Immunotherapy Revenue in Global Market (2018-2023)
7.2.5 HAL Allergy Group Key News & Latest Developments
7.3 Merck
7.3.1 Merck Company Summary
7.3.2 Merck Business Overview
7.3.3 Merck Subcutaneous Immunotherapy Major Product Offerings
7.3.4 Merck Subcutaneous Immunotherapy Revenue in Global Market (2018-2023)
7.3.5 Merck Key News & Latest Developments
7.4 Allergy Therapeutics
7.4.1 Allergy Therapeutics Company Summary
7.4.2 Allergy Therapeutics Business Overview
7.4.3 Allergy Therapeutics Subcutaneous Immunotherapy Major Product Offerings
7.4.4 Allergy Therapeutics Subcutaneous Immunotherapy Revenue in Global Market (2018-2023)
7.4.5 Allergy Therapeutics Key News & Latest Developments
7.5 ALK-Abello
7.5.1 ALK-Abello Company Summary
7.5.2 ALK-Abello Business Overview
7.5.3 ALK-Abello Subcutaneous Immunotherapy Major Product Offerings
7.5.4 ALK-Abello Subcutaneous Immunotherapy Revenue in Global Market (2018-2023)
7.5.5 ALK-Abello Key News & Latest Developments
7.6 Stallergenes Greer
7.6.1 Stallergenes Greer Company Summary
7.6.2 Stallergenes Greer Business Overview
7.6.3 Stallergenes Greer Subcutaneous Immunotherapy Major Product Offerings
7.6.4 Stallergenes Greer Subcutaneous Immunotherapy Revenue in Global Market (2018-2023)
7.6.5 Stallergenes Greer Key News & Latest Developments
7.7 Laboratorios LETI
7.7.1 Laboratorios LETI Company Summary
7.7.2 Laboratorios LETI Business Overview
7.7.3 Laboratorios LETI Subcutaneous Immunotherapy Major Product Offerings
7.7.4 Laboratorios LETI Subcutaneous Immunotherapy Revenue in Global Market (2018-2023)
7.7.5 Laboratorios LETI Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Subcutaneous Immunotherapy Market Opportunities & Trends in Global Market
Table 2. Subcutaneous Immunotherapy Market Drivers in Global Market
Table 3. Subcutaneous Immunotherapy Market Restraints in Global Market
Table 4. Key Players of Subcutaneous Immunotherapy in Global Market
Table 5. Top Subcutaneous Immunotherapy Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Subcutaneous Immunotherapy Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Subcutaneous Immunotherapy Revenue Share by Companies, 2018-2023
Table 8. Global Companies Subcutaneous Immunotherapy Product Type
Table 9. List of Global Tier 1 Subcutaneous Immunotherapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Subcutaneous Immunotherapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Subcutaneous Immunotherapy Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Subcutaneous Immunotherapy Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Subcutaneous Immunotherapy Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Subcutaneous Immunotherapy Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Subcutaneous Immunotherapy Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Subcutaneous Immunotherapy Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Subcutaneous Immunotherapy Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Subcutaneous Immunotherapy Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Subcutaneous Immunotherapy Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Subcutaneous Immunotherapy Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Subcutaneous Immunotherapy Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Subcutaneous Immunotherapy Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Subcutaneous Immunotherapy Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Subcutaneous Immunotherapy Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Subcutaneous Immunotherapy Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Subcutaneous Immunotherapy Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Subcutaneous Immunotherapy Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Subcutaneous Immunotherapy Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Subcutaneous Immunotherapy Revenue, (US$, Mn), 2024-2029
Table 30. Anergis Company Summary
Table 31. Anergis Subcutaneous Immunotherapy Product Offerings
Table 32. Anergis Subcutaneous Immunotherapy Revenue (US$, Mn) & (2018-2023)
Table 33. Anergis Key News & Latest Developments
Table 34. HAL Allergy Group Company Summary
Table 35. HAL Allergy Group Subcutaneous Immunotherapy Product Offerings
Table 36. HAL Allergy Group Subcutaneous Immunotherapy Revenue (US$, Mn) & (2018-2023)
Table 37. HAL Allergy Group Key News & Latest Developments
Table 38. Merck Company Summary
Table 39. Merck Subcutaneous Immunotherapy Product Offerings
Table 40. Merck Subcutaneous Immunotherapy Revenue (US$, Mn) & (2018-2023)
Table 41. Merck Key News & Latest Developments
Table 42. Allergy Therapeutics Company Summary
Table 43. Allergy Therapeutics Subcutaneous Immunotherapy Product Offerings
Table 44. Allergy Therapeutics Subcutaneous Immunotherapy Revenue (US$, Mn) & (2018-2023)
Table 45. Allergy Therapeutics Key News & Latest Developments
Table 46. ALK-Abello Company Summary
Table 47. ALK-Abello Subcutaneous Immunotherapy Product Offerings
Table 48. ALK-Abello Subcutaneous Immunotherapy Revenue (US$, Mn) & (2018-2023)
Table 49. ALK-Abello Key News & Latest Developments
Table 50. Stallergenes Greer Company Summary
Table 51. Stallergenes Greer Subcutaneous Immunotherapy Product Offerings
Table 52. Stallergenes Greer Subcutaneous Immunotherapy Revenue (US$, Mn) & (2018-2023)
Table 53. Stallergenes Greer Key News & Latest Developments
Table 54. Laboratorios LETI Company Summary
Table 55. Laboratorios LETI Subcutaneous Immunotherapy Product Offerings
Table 56. Laboratorios LETI Subcutaneous Immunotherapy Revenue (US$, Mn) & (2018-2023)
Table 57. Laboratorios LETI Key News & Latest Developments
List of Figures
Figure 1. Subcutaneous Immunotherapy Segment by Type in 2022
Figure 2. Subcutaneous Immunotherapy Segment by Application in 2022
Figure 3. Global Subcutaneous Immunotherapy Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Subcutaneous Immunotherapy Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Subcutaneous Immunotherapy Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Subcutaneous Immunotherapy Revenue in 2022
Figure 8. By Type - Global Subcutaneous Immunotherapy Revenue Market Share, 2018-2029
Figure 9. By Application - Global Subcutaneous Immunotherapy Revenue Market Share, 2018-2029
Figure 10. By Type - Global Subcutaneous Immunotherapy Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Subcutaneous Immunotherapy Revenue Market Share, 2018-2029
Figure 12. By Application - Global Subcutaneous Immunotherapy Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Subcutaneous Immunotherapy Revenue Market Share, 2018-2029
Figure 14. By Region - Global Subcutaneous Immunotherapy Revenue Market Share, 2018-2029
Figure 15. By Country - North America Subcutaneous Immunotherapy Revenue Market Share, 2018-2029
Figure 16. US Subcutaneous Immunotherapy Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Subcutaneous Immunotherapy Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Subcutaneous Immunotherapy Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Subcutaneous Immunotherapy Revenue Market Share, 2018-2029
Figure 20. Germany Subcutaneous Immunotherapy Revenue, (US$, Mn), 2018-2029
Figure 21. France Subcutaneous Immunotherapy Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Subcutaneous Immunotherapy Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Subcutaneous Immunotherapy Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Subcutaneous Immunotherapy Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Subcutaneous Immunotherapy Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Subcutaneous Immunotherapy Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Subcutaneous Immunotherapy Revenue Market Share, 2018-2029
Figure 28. China Subcutaneous Immunotherapy Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Subcutaneous Immunotherapy Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Subcutaneous Immunotherapy Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Subcutaneous Immunotherapy Revenue, (US$, Mn), 2018-2029
Figure 32. India Subcutaneous Immunotherapy Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Subcutaneous Immunotherapy Revenue Market Share, 2018-2029
Figure 34. Brazil Subcutaneous Immunotherapy Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Subcutaneous Immunotherapy Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Subcutaneous Immunotherapy Revenue Market Share, 2018-2029
Figure 37. Turkey Subcutaneous Immunotherapy Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Subcutaneous Immunotherapy Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Subcutaneous Immunotherapy Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Subcutaneous Immunotherapy Revenue, (US$, Mn), 2018-2029
Figure 41. Anergis Subcutaneous Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. HAL Allergy Group Subcutaneous Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Merck Subcutaneous Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Allergy Therapeutics Subcutaneous Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. ALK-Abello Subcutaneous Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Stallergenes Greer Subcutaneous Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Laboratorios LETI Subcutaneous Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
